Matisse Pharmaceuticals

Developing therapies to treat life-threatening inflammation

placeGeleen, Limburg, Netherlands calendar_todayFounded 2014 groups9 employees language matissepharmaceuticals.com

Social engagement

Social engagement: 798 social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

1 investor on record; lead investors include Brightlands Venture Partners.

Investor typeCountShare
Venture capital1100%
Coming soon